PEAK6 Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

PEAK6 Group’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-11,000	Closed	-$1.24M	–	5445
2017 Q2	$1.24M	Buy	11,000 +1,000	+10%	+$112K	0.01%	1743
2017 Q1	$1M	Sell	10,000 -22,000	-69%	-$2.35M	0.01%	1680
2016 Q4	$3.44M	Sell	32,000 -26,600	-45%	-$3.11M	0.02%	924
2016 Q3	$7.29M	Sell	58,600 -60,200	-51%	-$7.11M	0.05%	496
2016 Q2	$12.6M	Buy	118,800 +80,100	+207%	+$9.3M	0.1%	238
2016 Q1	$4.43M	Buy	38,700 +20,100	+108%	+$2.36M	0.04%	682
2015 Q4	$2.65M	Sell	18,600 -10,500	-36%	-$1.21M	0.02%	1139
2015 Q3	$2.61M	Sell	29,100 -500	-2%	-$52.8K	0.01%	1356
2015 Q2	$3.41M	Buy	29,600 +21,900	+284%	+$2.3M	0.02%	1086
2015 Q1	$735K	Buy	+7,700	New	+$576K	0.01%	2196

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PEAK6 Group's CBPO Position: Q2 2018 in Review

PEAK6 Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2018, closing a stake of 4,263 shares — an estimated $345K sold.

PEAK6 Group first reported a position in CBPO in Q3 2015 and held it in 7 quarters. The position peaked at $7.76M in Q3 2016. 91 funds tracked by Wall St. Rank hold CBPO as of Q2 2018.

PEAK6 Group reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2018 after selling out during the quarter.
PEAK6 Group sold 4,263 China Biologic Products Holdings, Inc. shares in Q2 2018, an estimated $345K.
PEAK6 Group first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 7 quarters.
PEAK6 Group's China Biologic Products Holdings, Inc. position peaked at $7.76M in Q3 2016.
91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.